We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Surgical Stabilization Improves Rib Fracture Outcomes

By HospiMedica International staff writers
Posted on 18 Feb 2020
Surgical stabilization of rib fracture (SSRF) improves outcomes of patients with displaced rib fractures in the absence of flail chest, claims a new study.

Denver Health Medical Center (CO, USA), Baystate Medical Center (Springfield, MA, USA), and other institutions conducted a prospective, controlled, clinical trial in 12 centers comparing SSRF within 72 hours to medical management in 110 patients with three or more ipsilateral, severely displaced rib fractures, but without flail chest; of these, 51 (46.4%) underwent SSRF. More...
The main outcome was numeric pain score (NPS) at two-week follow-up. Narcotic consumption, spirometry, pulmonary function tests, pleural space complications, and overall and respiratory disability-related quality of life were also compared.

The results showed that there were no significant baseline differences between operative and non-operative groups. At two week follow-up, the NPS was significantly lower in the operative (2.9) than in the non-operative group (4.5), and respiratory disability-related quality of life was also significantly improved. Narcotic consumption trended toward being lower in the operative, as compared with the non-operative group. During index admission, pleural space complications were significantly lower in the operative (0%), than in the non-operative group (10.2%). The study was published on February 5, 2020, in the Journal of Trauma and Acute Care Surgery.

“We demonstrated a significant improvement in the primary outcome of pain at two week follow-up in patients with displaced, non-flail fracture patterns who underwent SSRF, compared with non-operative management,” concluded lead author Fredric Pieracci, MD, MPH. “These data support a role for SSRF in patients without either clinical or radiographic flail chest, with recognition of trial inclusion criteria, including evidence of pulmonary derangements due to the fractures, early surgery, and performance of the operation at an experienced center.”

Flail chest is a traumatic condition of the thorax that occurs when at least three or more ribs are broken in at least two places. The injuries cause a segment of the chest wall to move independently of the rest of the chest wall, creating significant disturbance in respiratory function, including ineffective ventilation due to increased dead space, decreased intrathoracic pressure, and increased oxygen demand; edema and pulmonary contusion; and hypoventilation with atelectasis.

Related Links:
Denver Health Medical Center
Baystate Medical Center



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Syringes
Prefilled Saline Flush Syringes
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.